UTHR · Insider trading · 13F holders · Congress trades
UNITED THERAPEUTICS Corp (UTHR)
Who is buying and selling UTHR: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 79
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $338.8M
- Congress trades, 12 months
- 4
UTHR at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 3 UTHR insiders filed 71 sales worth $338.8M on SEC Form 4, and no open-market purchases; 70 of the sales were pre-planned under Rule 10b5-1.
- 79 13F filers hold UTHR among their 50 largest positions, worth $4.6B combined, including Behzad Aghazadeh, James Flynn and Jim Simons. The biggest bets by portfolio weight are Krensavage Asset Management, LLC (14.3%), Behzad Aghazadeh (13.5%) and Diadema Partners LP (10.9%). In their latest 13Fs, 2 managers opened a new position and 17 added to one.
- Members of Congress have disclosed 6 UTHR trades since 2015, 2 purchases and 2 sales in the past year; the latest was Lisa C. McClain (R-MI), selling $1K–15K on Oct 31, 2025.
- UTHR last closed at $593.54 on Oct 29, 2026.
UTHR insider trading
Between Aug 1, 2026 and Oct 29, 2026, 3 UTHR insiders filed 71 sales worth $338.8M on SEC Form 4, and no open-market purchases; 70 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $585.49 | $5.6M | SEC |
| Oct 28, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $587.73 | $5.6M | SEC |
| Oct 27, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $588.64 | $5.6M | SEC |
| Oct 26, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $582.76 | $5.5M | SEC |
| Oct 23, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $583.38 | $5.5M | SEC |
| Oct 22, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $560.07 | $5.3M | SEC |
| Oct 21, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $553.87 | $5.3M | SEC |
| Oct 20, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $543.32 | $5.2M | SEC |
| Oct 19, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $534.66 | $5.1M | SEC |
| Oct 16, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $546.65 | $5.2M | SEC |
| Oct 16, 2026 | Mahon Paul A | EVP & GENERAL COUNSEL | Sale10b5-1 | 8,300 | $544.30 | $4.5M | SEC |
| Oct 15, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $539.99 | $5.1M | SEC |
| Oct 14, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $545.52 | $5.2M | SEC |
| Oct 13, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $550.70 | $5.2M | SEC |
| Oct 13, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $544.94 | $5.2M | SEC |
| Oct 9, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $534.31 | $5.1M | SEC |
| Oct 8, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $548.95 | $5.2M | SEC |
| Oct 7, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $538.67 | $5.1M | SEC |
| Oct 6, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $541.64 | $5.1M | SEC |
| Oct 5, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $549.37 | $5.2M | SEC |
| Oct 2, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $576.47 | $5.5M | SEC |
| Oct 1, 2026 | Mahon Paul A | EVP & GENERAL COUNSEL | Sale10b5-1 | 8,300 | $564.95 | $4.7M | SEC |
| Oct 1, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 7,580 | $517.97 | $3.9M | SEC |
| Oct 1, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 1,920 | $550.22 | $1.1M | SEC |
| Sep 30, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | Sale10b5-1 | 9,500 | $477.42 | $4.5M | SEC |
Who owns UTHR? Hedge funds and superinvestors
79 13F filers hold UTHR among their 50 largest positions, worth $4.6B combined, including Behzad Aghazadeh, James Flynn and Jim Simons. The biggest bets by portfolio weight are Krensavage Asset Management, LLC (14.3%), Behzad Aghazadeh (13.5%) and Diadema Partners LP (10.9%). In their latest 13Fs, 2 managers opened a new position and 17 added to one.
Superinvestors holding UTHR: Behzad Aghazadeh 13.5% · James Flynn 3.1% · Jim Simons 1.3%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Behzad AghazadehHedge fund | 13.5% | $1.5B | 2,777,777 | +5.6% shares | Q2 2026 |
| Jim SimonsHedge fund | 1.3% | $925.8M | 1,708,739 | -4.4% shares | Q2 2026 |
| Assetmark, IncWealth manager | 0.5% | $325.2M | 600,171 | -3.8% shares | Q3 2026 |
| James FlynnHedge fund | 3.1% | $247.6M | 457,000 | +0.0% shares | Q2 2026 |
| Vestal Point Capital, LPHedge fund | 5.5% | $235.7M | 435,000 | +480.0% shares | Q2 2026 |
| Eversept Partners, LPHedge fund | 8.5% | $155.9M | 287,668 | +8.9% shares | Q2 2026 |
| Soleus Capital Management, L.P.Hedge fund | 4.2% | $122.2M | 225,587 | +20.5% shares | Q2 2026 |
| Frontier Capital Management Co LLCInstitutional asset manager | 1.0% | $112.1M | 206,808 | -18.2% shares | Q2 2026 |
| Bellevue Group AGInvestment manager | 2.1% | $102.1M | 188,515 | — | Q2 2026 |
| Deep Track Capital, LPHedge fund | 1.0% | $67.0M | 123,616 | — | Q2 2026 |
| Bowen Hanes & Co IncInstitutional asset manager | 1.2% | $50.4M | 85,000 | +0.0% shares | Q2 2026 |
| First Turn Management, LLCInstitutional asset manager | 4.9% | $46.0M | 84,932 | -18.9% shares | Q2 2026 |
| Portolan Capital Management, LLCMutual fund manager | 1.7% | $44.2M | 81,518 | +28.5% shares | Q2 2026 |
| Seizert Capital Partners, LLCInstitutional asset manager | 1.7% | $41.6M | 76,828 | -26.6% shares | Q2 2026 |
| Sofinnova Investments, Inc.Hedge fund | 2.2% | $41.4M | 76,489 | -52.2% shares | Q2 2026 |
| Krensavage Asset Management, LLCHedge fund | 14.3% | $37.5M | 69,282 | -17.8% shares | Q2 2026 |
| Palo Alto Investors LPHedge fund | 4.7% | $33.9M | 62,587 | -0.4% shares | Q2 2026 |
| Atwood & Palmer IncWealth manager | 1.7% | $33.0M | 60,976 | -0.8% shares | Q3 2026 |
| Axiom Investors LLC /deHedge fund | 0.3% | $29.5M | 54,437 | — | Q2 2026 |
| Diadema Partners LPHedge fund | 10.9% | $28.7M | 52,989 | +94.1% shares | Q2 2026 |
| Summit Street Capital Management, LLCHedge fund | 4.0% | $28.6M | 52,789 | -7.2% shares | Q2 2026 |
| PFM Health Sciences, LPHedge fund | 2.4% | $27.1M | 49,991 | +25.6% shares | Q2 2026 |
| Polaris Capital Management, LLCMutual fund manager | 2.8% | $26.5M | 48,950 | -8.4% shares | Q3 2026 |
| Tri Locum Partners LPHedge fund | 3.1% | $25.5M | 47,026 | -33.2% shares | Q2 2026 |
| Fideuram Asset Management (Ireland) dacAsset manager | 0.5% | $22.8M | 44,963 | — | Q3 2026 |
| Patient Square Capital LPHedge fund | 3.1% | $20.1M | 37,120 | New | Q2 2026 |
| Livforsakringsbolaget Skandia, OmsesidigtInvestment manager | 0.6% | $19.6M | 36,200 | -0.5% shares | Q3 2026 |
| Nepsis Inc.Wealth manager | 5.2% | $16.4M | 30,336 | +11.2% shares | Q3 2026 |
| Ardsley Advisory Partners LPHedge fund | 1.8% | $16.3M | 30,000 | -40.0% shares | Q2 2026 |
| Sawgrass Asset Management LLCInstitutional asset manager | 1.9% | $14.3M | 26,461 | +5.4% shares | Q2 2026 |
The 30 largest of 79 positions, by value. Each manager counts with its latest 13F (Q3 2026: 24, Q2 2026: 54, Q1 2026: 1). Screen UTHR in the grand portfolio →
UTHR stock trades by members of Congress
Members of Congress have disclosed 6 UTHR trades since 2015, 2 purchases and 2 sales in the past year; the latest was Lisa C. McClain (R-MI), selling $1K–15K on Oct 31, 2025.
| Filed | Member | Trade | Amount | Traded | Since |
|---|---|---|---|---|---|
| Nov 21, 2025 | Lisa C. McClainR-MI · House | Sale | $1K–15K | Oct 31, 2025 | +34.4% |
| Nov 21, 2025 | Lisa C. McClainR-MI · House | Sale | $1K–15K | Oct 30, 2025 | +32.0% |
| Nov 21, 2025 | Lisa C. McClainR-MI · House | Buy | $1K–15K | Oct 30, 2025 | +32.0% |
| Aug 13, 2025 | Lisa C. McClainR-MI · House | Buy | $1K–15K | Jun 11, 2025 | +116.5% |
| Apr 27, 2020 | Donna E. ShalalaD-FL · House | Sale | $1K–15K | Mar 6, 2019 | +438.3% |
| Jun 7, 2015 | Thomas MacArthurR-NJ · House | Sale | $1K–15K | May 27, 2015 | +226.2% |
3 members have traded UTHR: Lisa C. McClain, Donna E. Shalala, Thomas MacArthur.
Analysis mentioning UTHR
Posts from the blog that cover UNITED THERAPEUTICS Corp, newest first.
- Insider selling · Oct 29, 2026Insider Selling on October 29, 2026: DVA, STRZ and TALO Lead $311.4M of Sales
- Insider selling · Oct 28, 2026Insider Selling on October 28, 2026: INSW, MEDP and R Lead $113.9M of Sales
- Insider selling · Oct 27, 2026Insider Selling on October 27, 2026: TALO, GS and ALMR Lead $131.1M of Sales
- Insider selling · Oct 26, 2026Insider Selling on October 26, 2026: ISRG, CRL and LRCX Lead $70.5M of Sales
- Insider selling · Oct 23, 2026Insider Selling on October 23, 2026: TRV, INNV and SNOW Lead $172.6M of Sales
- Insider selling · Oct 22, 2026Insider Selling on October 22, 2026: BRZE, BROS and TRV Lead $95.5M of Sales
- Insider selling · Oct 21, 2026Insider Selling on October 21, 2026: SNOW, TALO and CVX Lead $204.8M of Sales
- Insider selling · Oct 20, 2026Insider Selling on October 20, 2026: MU, GRND and UTHR Lead $55.0M of Sales
UTHR questions and answers
Are insiders buying UTHR stock?
Between Aug 1, 2026 and Oct 29, 2026, 3 UTHR insiders filed 71 sales worth $338.8M on SEC Form 4, and no open-market purchases; 70 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own UTHR?
79 13F filers hold UTHR among their 50 largest positions, worth $4.6B combined, including Behzad Aghazadeh, James Flynn and Jim Simons. The biggest bets by portfolio weight are Krensavage Asset Management, LLC (14.3%), Behzad Aghazadeh (13.5%) and Diadema Partners LP (10.9%). In their latest 13Fs, 2 managers opened a new position and 17 added to one.
Has Congress traded UTHR?
Members of Congress have disclosed 6 UTHR trades since 2015, 2 purchases and 2 sales in the past year; the latest was Lisa C. McClain (R-MI), selling $1K–15K on Oct 31, 2025.
Who is the largest holder of UTHR?
Among 13F filers, Behzad Aghazadeh reports the largest UTHR position, $1.5B (2,777,777 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Krensavage Asset Management, LLC's: 14.3% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.